Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?
Journal: Therapeutic advances in hematology
Published: February 23, 2026
Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes.
Journal: Pediatric blood & cancer
Published: December 23, 2025
Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 12, 2024
Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1.
Journal: Frontiers in pediatrics
Published: July 15, 2024
SARS-CoV-2 infection coincident with newly diagnosed severe aplastic anemia: A report of two cases.
Journal: Pediatric blood & cancer
Published: October 17, 2021
The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells.
Journal: EBioMedicine
Published: June 23, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026